Safety of insulin glargine.
Berger
M
M
D002273:Carcinogens / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000031:analogs & derivatives*; D008934:Mitogens / Q000009:adverse effects
D002273:Carcinogens; D007004:Hypoglycemic Agents; D007328:Insulin; D008934:Mitogens